New combo may boost stem cell harvest for lymphoma patients
NCT ID NCT06520163
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of three drugs (etoposide, cytarabine, and PEG-rhG-CSF) works better than standard chemotherapy at collecting enough stem cells for a transplant in people with non-Hodgkin's lymphoma. About 99 participants who are in remission will be randomly assigned to one of two groups. The main goal is to see if more patients in the new drug group can collect a high number of stem cells in a single session.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC STEM CELL MOBILIZATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dongyang People's Hospital
RECRUITINGDongyang, Zhejiang, China
-
Huzhou central hospital
RECRUITINGHuzhou, Zhejiang, China
-
Jinhua Municipal Central Hospital
RECRUITINGJinhua, Zhejiang, China
-
Jinhua People's Hospital
RECRUITINGJinhua, Zhejiang, China
-
Lishui Central Hospital
RECRUITINGLishui, Zhejiang, China
-
Ningbo Medical Center Lihuili Hospital
RECRUITINGNingbo, Zhejiang, China
-
Shaoxing People's Hospital
RECRUITINGShaoxing, Zhejiang, China
-
Shaoxing Second Hospital
RECRUITINGShaoxing, Zhejiang, China
-
Taizhou Central Hospital
RECRUITINGTaizhou, Zhejiang, China
-
Taizhou Hospital of Zhejiang Province
RECRUITINGTaizhou, Zhejiang, China
-
The Affiliated Hangzhou First People's Hospital
RECRUITINGHangzhou, Zhejiang, 310006, China
-
The Affiliated People's Hospital of Ningbo University
RECRUITINGNingbo, Zhejiang, China
-
The First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, China
-
The First Affiliated Hospital, College of Medicine, Zhejiang University
RECRUITINGHangzhou, Zhejiang, China
-
The First Hospital of Jiaxing
RECRUITINGJiaxing, Zhejiang, China
-
The Second Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, Zhejiang, China
-
Tongde Hospital of Zhejiang Province
RECRUITINGHangzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Supercharged immune cells take aim at cancer and viruses in one shot
- Engineered t cells with a kill switch aim to make stem cell transplants safer
- Gut bacteria may hold key to chemo side effects
- New 'In-Body' CAR-T therapy takes aim at Hard-to-Treat lymphoma
- Experimental 'In-Situ' vaccine aims to train immune system against three cancers
- Scientists hunt for lymphoma genes in families with multiple cases